KRAS and colorectal carcinoma: Taken together, these experiments demonstrate that cells expressing mutant KRAS can transfer mutant KRAS to wild-type KRAS CRC cells and that this transfer is reduced when TNT formation between the two cell populations is diminished physically and pharmacologically.